Sun, Apr 20, 2014, 4:01 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Momenta Pharmaceuticals Inc. Message Board

  • ding_king2000 ding_king2000 Apr 14, 2013 9:19 AM Flag

    Duplicating biologics is infinitely much more complex than duplicating the traditional drug compounds. I say MNTA's chances of being successful duplicating the biologics they have chosen is not very good, I reckon. I believe there was an article in the WSJ that supports this thesis. One thing I do know, is an equity raise by MNTA should be quite soon as they are burning through a huge amount of cash..

    Somebody has to be the pioneer..

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • The first part of this message is indisputable.. After further review, I will take back the need for cash in the short term. Biotechs will be virtually impossible to copy, and will take an enormous amount of money and more importantly time to pull off.

    • More BS from Ding_king

      {{Duplicating biologics is infinitely much more complex than duplicating the traditional drug compounds.}}

      It is more complicated, but of course it isn't infinitely more complicated.

      {{I say MNTA's chances of being successful duplicating the biologics they have chosen is not very good, I reckon.}}

      Feel free to espouse your opinion. In my view your opinions are worthless as you don't seem to have even a rudimentary understanding of science, the FDA or even basic facts about MNTA.

      {{I believe there was an article in the WSJ that supports this thesis. }}

      Post the article and we will discuss it's merits, or lack thereof.

      {{One thing I do know, is an equity raise by MNTA should be quite soon as they are burning through a huge amount of cash..}}

      Just for laughs I reposted your absurd comment. I already responded to it and showed how uninformed you are and how wrong you are.

    • Ding_king, you cannot be serious, can you?

      {{One thing I do know, is an equity raise by MNTA should be quite soon as they are burning through a huge amount of cash..}}

      Ha, Ha. I guess this means you DON'T know a SINGLE thing. MNTA has about $350 million in cash on hand and no debt. Their burn rate is maybe $60-$75 million/year. There will be no need for a secondary for quite sometime.

 
MNTA
11.10-0.46(-3.98%)Apr 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
AsiaInfo-Linkage, Inc.
NasdaqGSWed, Jan 15, 2014 4:00 PM EST